Equalapp

Asimov Inc, based in Boston, MA, is at the forefront of engineering biology, focusing on creating tools for genetic designers to revolutionize the field. Founded by experts from prominent institutions, the company aims to transition genetic engineering into a fully-fledged engineering discipline through advanced computer-aided design platforms. Since its inception in 2017, Asimov has integrated state-of-the-art synthetic biology research with computational tools, pioneering innovations such as the Cello platform for automated genetic circuit design. The company's collaborative roots in prestigious labs underscore its commitment to advancing the precision and reliability of complex genetic systems. Generated from the website